When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus
- PMID: 32016348
- DOI: 10.1093/jac/dkz559
When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus
Abstract
Staphylococcus aureus is a major human pathogen causing a vast array of infections with significant mortality. Its versatile physiology enables it to adapt to various environments. Specific physiological changes are thought to underlie the frequent failure of antimicrobial therapy despite susceptibility in standard microbiological assays. Bacteria capable of surviving high antibiotic concentrations despite having a genetically susceptible background are described as 'antibiotic tolerant'. In this review, we put current knowledge on environmental triggers and molecular mechanisms of increased antibiotic survival of S. aureus into its clinical context. We discuss animal and clinical evidence of its significance and outline strategies to overcome infections with antibiotic-tolerant S. aureus.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Mechanisms of Antibiotic Failure During Staphylococcus aureus Osteomyelitis.Front Immunol. 2021 Feb 12;12:638085. doi: 10.3389/fimmu.2021.638085. eCollection 2021. Front Immunol. 2021. PMID: 33643322 Free PMC article. Review.
-
Assessing Antibiotic Tolerance of Staphylococcus aureus Derived Directly from Patients by the Replica Plating Tolerance Isolation System (REPTIS).Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0096721. doi: 10.1128/AAC.00967-21. Epub 2021 Oct 25. Antimicrob Agents Chemother. 2022. PMID: 34694884 Free PMC article.
-
Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.Infect Immun. 2021 Mar 17;89(4):e00694-20. doi: 10.1128/IAI.00694-20. Print 2021 Mar 17. Infect Immun. 2021. PMID: 33526569 Free PMC article. Review.
-
Mechanism of staphylococcal resistance to clinically relevant antibiotics.Drug Resist Updat. 2024 Nov;77:101147. doi: 10.1016/j.drup.2024.101147. Epub 2024 Aug 31. Drug Resist Updat. 2024. PMID: 39236354 Review.
-
Molecular reprogramming and phenotype switching in Staphylococcus aureus lead to high antibiotic persistence and affect therapy success.Proc Natl Acad Sci U S A. 2021 Feb 16;118(7):e2014920118. doi: 10.1073/pnas.2014920118. Proc Natl Acad Sci U S A. 2021. PMID: 33574060 Free PMC article.
Cited by
-
Antimicrobial Activity of Non-steroidal Anti-inflammatory Drugs on Biofilm: Current Evidence and Potential for Drug Repurposing.Front Microbiol. 2021 Jul 27;12:707629. doi: 10.3389/fmicb.2021.707629. eCollection 2021. Front Microbiol. 2021. PMID: 34385992 Free PMC article.
-
Inhibition of Erythromycin and Erythromycin-Induced Resistance among Staphylococcus aureus Clinical Isolates.Antibiotics (Basel). 2023 Mar 2;12(3):503. doi: 10.3390/antibiotics12030503. Antibiotics (Basel). 2023. PMID: 36978370 Free PMC article.
-
Virulence characteristics of Gram-positive bacteria isolated from diabetic foot ulcers.FEMS Microbes. 2024 May 6;5:xtae013. doi: 10.1093/femsmc/xtae013. eCollection 2024. FEMS Microbes. 2024. PMID: 38783991 Free PMC article.
-
The effect of novel β-lactam derivatives synthesized from substituted phenethylamines on resistance genes of MRSA isolates.J Antibiot (Tokyo). 2024 Dec;77(12):802-811. doi: 10.1038/s41429-024-00769-5. Epub 2024 Aug 29. J Antibiot (Tokyo). 2024. PMID: 39210001
-
Trained immunity in recurrent Staphylococcus aureus infection promotes bacterial persistence.PLoS Pathog. 2024 Jan 19;20(1):e1011918. doi: 10.1371/journal.ppat.1011918. eCollection 2024 Jan. PLoS Pathog. 2024. PMID: 38241414 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical